Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
portfolio is the world's largest early development pipeline of new antibiotics, vaccines, rapid diagnostics and other products to prevent, diagnose and treat life-threatening bacterial infections. CARB-X is
-
this goal, we develop/adapt tools, do rigorous measurements, and define new concepts. We are currently searching for simple yet fundamental rules connecting the complicated form of bacterial cells and their
-
) (www.stradivarious.eu ) is a European-wide intersectoral doctoral training network focussed on focus on emerging bacterial threats – specifically the ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus
-
and bacterial genetic approaches required for the project. - To perform the approaches related to protein biochemistry required in the frame of the project. - To perform the optical and electronic
-
, collaborate with national and international partners, and contribute to publications and grant development. Responsibilities Conduct bioinformatic analyses of bacterial and fungal amplicon sequencing (16S, ITS
-
? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description Bacterial biofilms are ubiquitous and play a critical role in many aspects
-
/medizinische-mikrobiologie-und-krankenhaushygiene/forschung/kempf Izadi-Prunyere website: https://research.pasteur.fr/en/team/bacterial-transmembrane-systems/ Corticalis website: https://www.corticalis.no
-
is also known for the development of the Nanoimager microscope and the founding of Oxford Nanoimaging (https://oni.bio/ ). The group recently moved in the new Kavli Institute for Nanoscience Discovery
-
, PNAS 2020; Mazumder, eLife 2021; El Sayyed et al Mol Cell 2024). The group is also known for the development of the Nanoimager microscope and the founding of Oxford Nanoimaging ( https://oni.bio
-
of people and often leading to reduced quality of life, hospitalization, amputations, and even premature death. A key obstacle in treating these infections is the formation of bacterial biofilms, which make